Nicotinell Med Fruktsmak

Nicotine, the active ingredient in Nicotinell Med Fruktsmak, is a nicotine replacement therapy presented as a buccal lozenge for buccal use. It helps adult smokers who wish to quit by reducing nicotine withdrawal symptoms and cravings.\n\nGNH India supplies Nicotinell Med Fruktsmak as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell Med Fruktsmak is a nicotine replacement product used in the management of tobacco dependence.\n\n- Smoking cessation: assists adults in quitting smoking by alleviating cravings and withdrawal discomfort.\n- Tobacco use disorder: provides a controlled nicotine source to replace cigarettes during the quitting process.\n- Relapse prevention: helps maintain abstinence after initial cessation by offering a lower‑dose nicotine alternative.

Nicotinell Med Fruktsmak may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Mouth irritation or soreness\n- Nausea or upset stomach\n- Hiccups\n- Dyspepsia\n- Headache\n- Dizziness\n\nSerious or Rare Side Effects:\n- Allergic reaction (rash, itching, swelling)\n- Throat swelling or difficulty breathing\n- Chest pain or palpitations\n- Severe hypertension

When considering Nicotinell Med Fruktsmak, several safety measures should be observed.\n\n- Cardiovascular assessment: evaluate patients with recent myocardial infarction or unstable angina.\n- Hypertension monitoring: use with caution in uncontrolled high blood pressure.\n- Non‑smoker restriction: not intended for individuals who do not use tobacco.\n- Pediatric safety: keep out of reach of children to prevent accidental ingestion.\n- Pregnancy and lactation: discuss risks with a healthcare professional before use.\n- Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine may interact with other medicines, altering their effects or increasing adverse reactions.\n\nMajor Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): may exacerbate hypertensive response.\n- Insulin or oral hypoglycemics: nicotine can affect blood glucose control.\n\nModerate Interactions (Monitor Closely):\n- Beta‑blockers: monitor heart rate and blood pressure.\n- Antidepressants (SSRIs, SNRIs): watch for increased anxiety or insomnia.\n- Caffeine: potential for heightened stimulant effects.